Fortrea Holdings (FTRE) Cash from Financing Activities (2022 - 2025)

Fortrea Holdings (FTRE) reported Cash from Financing Activities of -$75.7 million for Q4 2025, down 6781.82% on a YoY basis from $1.1 million in Q4 2024, and down 51.4% quarter-over-quarter from -$50.0 million in Q3 2025.

Fortrea Holdings (FTRE) Cash from Financing Activities (2022 - 2025) Analysis & Trends

Fortrea Holdings has reported Cash from Financing Activities for 4 years, with the latest figure at -$75.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 6781.82% year-over-year to -$75.7 million; the trailing twelve-month figure through Mar 2026 stood at -$164.7 million (up 61.76% YoY), and the FY2025 full-year result was -$76.3 million, up 84.67% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at -$75.7 million, down from -$50.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $88.4 million in Q1 2025, with the low at -$504.0 million in Q2 2024.
  • Historically, Cash from Financing Activities has averaged -$54.8 million across 4 years, with a median of -$10.8 million in 2023.
  • The largest YoY upside for Cash from Financing Activities was 315.02% in 2025 against a maximum downside of 6781.82% in 2025.
  • Fortrea Holdings' Cash from Financing Activities stood at -$5.9 million in 2022, then tumbled by 30.51% to -$7.7 million in 2023, then jumped by 85.71% to -$1.1 million in 2024, then tumbled by 6781.82% to -$75.7 million in 2025.
  • The last three Cash from Financing Activities figures came in at -$75.7 million (Q4 2025), -$50.0 million (Q3 2025), and -$39.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -75.70 Mn
Dec 31, 2025 -75.70 Mn
Sep 30, 2025 -50.00 Mn
Sep 30, 2025 -50.00 Mn
Jun 30, 2025 -39.00 Mn
Jun 30, 2025 -39.00 Mn
Mar 31, 2025 88.40 Mn
Mar 31, 2025 88.40 Mn
Dec 31, 2024 -1.10 Mn
Dec 31, 2024 -1.10 Mn
Sep 30, 2024 -14.00 Mn
Sep 30, 2024 -14.00 Mn
Jun 30, 2024 -504.00 Mn
Jun 30, 2024 -504.00 Mn
Mar 31, 2024 21.30 Mn
Mar 31, 2024 21.30 Mn
Dec 31, 2023 -7.70 Mn
Dec 31, 2023 -7.70 Mn
Sep 30, 2023 -7.70 Mn
Sep 30, 2023 -7.70 Mn